They Test Plants To Attack Breast Cancer

Have you heard about chilillo, a medicinal plant with supposed anti-cancer properties?

With more in-depth research, in the future it may not only serve to attack a single type of cancer, but also others such as oral cancer the one with which the dentists in Tijuana are having many problems. In collaboration with private companies, went from myth to reality and verified in the laboratory the curative potential of this species (Phyllantus acuminatus), work that will allow them to work on a product to combat breast cancer

The fame of that specimen, a bush or tree whose leaves and seeds are prepared in a homemade tea with the hope of curing all types of cancer, had to be verified scientifically.

For this reason, since 2015, a group of specialists from the Biotechnology Research Center of this higher education institution has dedicated itself to reproducing the seeds of the plant, in vitro, in the laboratory.

For the women
Why a proposal specifically against breast cancer? Because, although the qualities of the plant would apply to treat cancer in general, the breast is one of the highest incidence in the country.

1,100 women with this condition are diagnosed per year. That is, every eight hours a woman is diagnosed with that disease.

Three stage project
What’s next now? As explained by Garro, who is also a specialist in plant biotechnology, the research consists of three stages.

The first, that of validation with cancer cells, has already been overcome. Now follows the experimentation with mice and then the clinical tests (in humans).

The tests with the rodents will be carried out during the next weeks in Larkin University, in the United States, in a center specialized in such explorations.

If it’s positive. In a short time we hope to start with the clinical tests; that is, in human beings.

The expert added that, later, they will work with prostate cancer cells with the same plant.

If the research concludes successfully, the objective is to bring the product to market under the commercialization.

The contribution we have as a company is the phytochemical characterization. We have specialized equipment in gas chromatography coupled to masses, equipment with very little access or very expensive.

It is not yet known what the prototype’s presentation will be. The experts must define if it would be an infusion, capsules, or if it would have another aspect.